VWA
DNA icon

VSM Wealth Advisory’s Ginkgo Bioworks DNA Stock Holding History

VSM Wealth Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13K Hold
1,000
– – ﹤0.01% 397
2025
Q4 		$8.31K Hold
1,000
– – ﹤0.01% 351
2025
Q3 		$14.6K Hold
1,000
– – ﹤0.01% 307
2025
Q2 		$11.3K Hold
1,000
– – ﹤0.01% 367
2025
Q1 		$5.7K Buy
+1,000
New +$10.2K ﹤0.01% 397

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VSM Wealth Advisory's DNA Position: Q1 2026 in Review

VSM Wealth Advisory held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 1,000 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

VSM Wealth Advisory first reported a position in DNA in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.6K in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • VSM Wealth Advisory held 1,000 shares of Ginkgo Bioworks worth $6.13K as of Q1 2026.
  • VSM Wealth Advisory left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of VSM Wealth Advisory's portfolio in Q1 2026, its #397 holding.
  • VSM Wealth Advisory first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 5 quarters since.
  • VSM Wealth Advisory's Ginkgo Bioworks position peaked at $14.6K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on VSM Wealth Advisory's 13F filing for Q1 2026, filed 6 May 2026.